Is doxycycline (doxy) effective against Finegoldia magna?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline's Effectiveness Against Finegoldia magna

Doxycycline is moderately effective against Finegoldia magna, with approximately 72% of isolates showing susceptibility, but antimicrobial susceptibility testing is mandatory before using it for targeted treatment of F. magna infections. 1

Antimicrobial Susceptibility Profile

Finegoldia magna (formerly known as Peptococcus magnus or Peptostreptococcus magnus) is an anaerobic gram-positive coccus that can cause various infections including:

  • Skin and soft tissue infections
  • Orthopedic infections
  • Deep-seated abscesses
  • Diabetic foot infections
  • Periprosthetic joint infections

Recent research on F. magna susceptibility shows:

  • First-line options (nearly 100% susceptibility):

    • Benzylpenicillin
    • Amoxicillin/clavulanic acid
    • Metronidazole 1
  • Variable susceptibility options:

    • Doxycycline: 72% of isolates below ECOFF (epidemiological cutoff values) 1
    • Clindamycin: 75-93.3% susceptibility 1, 2
    • Penicillin: 86.4-87.4% susceptibility 2

Clinical Implications

When treating F. magna infections:

  1. For empiric therapy: Choose benzylpenicillin, amoxicillin/clavulanic acid, or metronidazole as first-line options

  2. For doxycycline use:

    • Antimicrobial susceptibility testing is mandatory before using doxycycline for targeted therapy 1
    • Doxycycline should not be relied upon empirically for F. magna infections
  3. For polymicrobial infections:

    • F. magna is often found in polymicrobial infections
    • These cases may require more surgical procedures and have higher failure rates than monomicrobial infections 3

Important Considerations

  • F. magna is part of the normal human microbiota but can cause opportunistic infections
  • When isolated in pure culture from appropriate samples, species identification and antimicrobial susceptibility testing are crucial 4
  • In the context of sexually transmitted infections, doxycycline is effective against many pathogens but may not provide reliable coverage for F. magna without susceptibility testing 5

Conclusion

While doxycycline has activity against many F. magna strains, it should not be considered a reliable empiric choice for these infections. When F. magna is suspected or confirmed, antimicrobial susceptibility testing is essential if considering doxycycline as treatment.

References

Research

Antimicrobial susceptibility testing is crucial when treating Finegoldia magna infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022

Research

Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010

Research

[Nonpuerperal breast abscess caused by Finegoldia magna].

Revista Argentina de microbiologia, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.